nih3t3 mouse fibroblast cells (ATCC)
Structured Review

Nih3t3 Mouse Fibroblast Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 118 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+fibroblast+nih3t3/NIH+3T3+Mouse+Fibroblast+Cells%2C+SR-3T3/pmc12968391-45-5-13
Average 96 stars, based on 118 article reviews
Images
1) Product Images from "Repeat-rich RNA guides repetitive genomic elements into biomolecular condensates for heterochromatin organization and muscle integrity"
Article Title: Repeat-rich RNA guides repetitive genomic elements into biomolecular condensates for heterochromatin organization and muscle integrity
Journal: Nucleic Acids Research
doi: 10.1093/nar/gkag168
Figure Legend Snippet: CU-rich RNA promotes heterochromatin condensate organization during differentiation. ( A ) Nuclei of C2C12 myotubes (MT) treated with 1.5% 1,6-hexanediol (1,6-HD) or 1.5% 2,5-hexanediol (2,5-HD). Left: Representative images of 4,6-diamidino-2-phenylindole (DAPI)-stained nuclei. Scale bar, 5 μm. Middle: Time-course quantification of the number of heterochromatin foci per nucleus. Right: Boxplots show foci area (μm 2 , y -axis) at 5, 10, and 15 min posttreatment ( x -axis). n = 55 nuclei, three biological replicates. ( B ) Representative live-cell images of Hoechst 33342-stained MT nuclei before and after 1,6-HD treatment (0 and 15 min, respectively), taken from . Arrows indicate changes in heterochromatin foci intensity (pink, increased; blue, decreased), and the red arrow highlights an alteration in chromocenter integrity. ( C ) Number of heterochromatin foci per nucleus in MT following recovery from 1.5% 1,6-hexanediol (1,6-HD) treatment for 15 min, measured at indicated time points. n = 68 nuclei, three biological replicates. ( D ) Representative images of nuclei of myoblast (MB) and MT with or without 1,6-HD treatment (1.5%, 15 min). Right: Quantification of the number of heterochromatin foci per nucleus. n = 40 (MB), n = 60 (MT), three biological replicates. ( E ) Quantification of colocalization between indicated proteins and DAPI foci in MT with or without 1,6-HD treatment (1.5%, 15 min), by Pearson’s correlation coefficients. n = 60, three biological replicates. ( F ) Boxplot showing the distribution of Z -score of the interchromosomal interaction frequencies in MB and MT. ( G ) RNA FISH using ChRO1 and LacZ biotinylated probes. Biotin signal was detected by Fluorescein-conjugated Avidin DCS and amplified with biotinylated anti-Avidin and additional Fluorescein Avidin DCS. Right: Quantification of colocalization between biotin signal and DAPI foci. n = 50 nuclei. ( H ) Number of heterochromatin foci per nucleus of mouse fibroblast cells (NIH3T3) with or without doxycyline (Dox)-induced ChRO1a expression and/or 1,6-HD treatment (1.5%, 15 min). (EV; empty vector). n = 50, three biological replicates. ( I ) Number of heterochromatin foci per nucleus in MB with or without Dox-induced ChRO1a fragment (1–413, CUR) expression and/or 1,6-HD treatment (1.5%, 15 min). n = 75, three biological replicates. Statistical analyses and data presentation details are described in the “Materials and methods” section.
Techniques Used: Staining, Avidin-Biotin Assay, Amplification, Expressing, Plasmid Preparation
Related Articles
other:Article Title: Antibody-pyrrolobenzodiazepine derivative conjugate which binds caludin-6 and claudin-9 Article Snippet: Particularly, examples of animal cells may include, but not limited to, mammalian cells, such as COS cells (Cell (1981) 23, p. 175-182, ATCC CRL-1650), as monkey cells, the Article Title: Methods for treating autoimmune diseases incorporating an anti-LAG3 antibody Article Snippet: Cell (1981), 23, p. 175-182, ATCC CRL-1650), Article Title: Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate Article Snippet: For such SG (10) glycan, for example, that obtained from SGP through hydrolysis or the like may be used, or SG (10) glycan such as commercially available disialooctasaccharide (Tokyo Chemical Industry Co., Ltd.) may be used. Article Title: Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1 Article Snippet: Human embryonic kidney HEK293T (CRL-3216), human colon cancer SW620 (CCL-227), HCT 116 (CCL-247), human pancreas cancer AsPC-1 (CRL-1682), MIA PaCa-2 (CRM-CRL-1420), human lung cancer NCI-H460 (HTB-177), A549 (CRM-CCL-185), mouse colon cancer CT-26 (CRL-2638), mouse fibroblast NIH3T3 (CRL-1658), mouse embryonic fibroblast MEF (CRL-2991), and Article Title: Method of treating ectopic ossification or diffuse intrinsic pontine glioma in a subject by administering an anti-ALK2 antibody Article Snippet: Examples of the animal cells may include mammalian cells, for example, simian COS cells (Gluzman, Y., Cell (1981) 23, p. 175-182, ATCC CRL-1650), Article Title: Targeting oncogenic K-RAS mutants with small-molecule degrader XMU-MP-9 through NEDD4-1 Article Snippet: Human embryonic kidney HEK293T (CRL-3216), human colon cancer SW620 (CCL-227), HCT 116 (CCL-247), human pancreas cancer AsPC-1 (CRL-1682), MIA PaCa-2 (CRM-CRL-1420), human lung cancer NCI-H460 (HTB-177), A549 (CRM-CCL185), mouse colon cancer CT-26 (CRL-2638), mouse fibroblast NIH3T3 (CRL-1658), mouse embryonic fibroblast MEF (CRL2991), and Article Title: Method for depleting cytotoxic T cells using an anti-LAG-3 antibody composition Article Snippet: Cell (1981), 23, p. 175-182, ATCC CRL-1650), Article Title: Combination of antibody-pyrrolobenzodiazepine derivative conjugate and PARP inhibitor Article Snippet: Particularly, examples of animal cells may include, but are not limited to, mammalian cells, such as COS cells (Cell (1981) 23, p. 175-182, ATCC CRL-1650), as monkey cells, the |
